Venous Malformation
16
4
4
8
Key Insights
Highlights
Success Rate
89% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
6.3%
1 terminated out of 16 trials
88.9%
+2.3% vs benchmark
19%
3 trials in Phase 3/4
13%
1 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (16)
Intralesional Bleomycin Sclerotherapy for Low-Flow Vascular Malformations of the Head and Neck
Complications of Ethanol-amine Oleate Intralesional Sclerotherapy
A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations
Trametinib in the Treatment of Complicated Extracranial Arterial Venous Malformation
A Study to Evaluate the Efficacy and Safety of Everolimus in Patients With Teratment-refractory Vascular Anomalies
Weekly Sirolimus Therapy
National Evaluation of Patients With PIK3CA-Related Overgrowth Spectrum (PROS)
Efficacy and Safety Analysis of Polylauric Alcohol More Stable Foam Versus Ordinary Foam in the Treatment of Head and Neck Venous Malformations
A Study of Enalapril in Treatment of Venous Malformations
Compare Two Different Sclerosing Agents in the Treatment of Venous Malformations
Electromagnetic Navigation During Ultrasound Guided Foam Sclerotherapy for Venous Malformations
Treatment of Venous Malformation
First in Human Trial of Topical VT30 in Pts With Venous/Lymphatic Malformations Assoc With PIK3CA or TEK Gene Mutations
Vascular Anomaly Pathology and Genomics Biopsy Study
Influence of Flat-knitted Compression Stockings Class I and II on Venous Malformations
Efficacy of Rapamycin (Sirolimus) in the Treatment of BRBNS, Hereditary or Sporadic Venous Malformation